全文获取类型
收费全文 | 50838篇 |
免费 | 4296篇 |
国内免费 | 186篇 |
专业分类
耳鼻咽喉 | 498篇 |
儿科学 | 1912篇 |
妇产科学 | 1213篇 |
基础医学 | 6638篇 |
口腔科学 | 799篇 |
临床医学 | 5913篇 |
内科学 | 9473篇 |
皮肤病学 | 989篇 |
神经病学 | 5377篇 |
特种医学 | 1259篇 |
外国民族医学 | 1篇 |
外科学 | 6000篇 |
综合类 | 774篇 |
一般理论 | 59篇 |
预防医学 | 6410篇 |
眼科学 | 718篇 |
药学 | 3486篇 |
1篇 | |
中国医学 | 83篇 |
肿瘤学 | 3717篇 |
出版年
2023年 | 607篇 |
2022年 | 1014篇 |
2021年 | 1965篇 |
2020年 | 1180篇 |
2019年 | 1722篇 |
2018年 | 1928篇 |
2017年 | 1413篇 |
2016年 | 1458篇 |
2015年 | 1583篇 |
2014年 | 2109篇 |
2013年 | 2736篇 |
2012年 | 3965篇 |
2011年 | 4044篇 |
2010年 | 2163篇 |
2009年 | 1859篇 |
2008年 | 2876篇 |
2007年 | 2791篇 |
2006年 | 2650篇 |
2005年 | 2467篇 |
2004年 | 2171篇 |
2003年 | 1964篇 |
2002年 | 1811篇 |
2001年 | 745篇 |
2000年 | 651篇 |
1999年 | 571篇 |
1998年 | 337篇 |
1997年 | 286篇 |
1996年 | 301篇 |
1995年 | 249篇 |
1994年 | 220篇 |
1993年 | 201篇 |
1992年 | 396篇 |
1991年 | 387篇 |
1990年 | 395篇 |
1989年 | 352篇 |
1988年 | 303篇 |
1987年 | 310篇 |
1986年 | 243篇 |
1985年 | 265篇 |
1984年 | 239篇 |
1983年 | 174篇 |
1982年 | 163篇 |
1981年 | 138篇 |
1980年 | 139篇 |
1979年 | 180篇 |
1978年 | 155篇 |
1977年 | 117篇 |
1976年 | 109篇 |
1974年 | 143篇 |
1973年 | 122篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
William R. C. Knight Cara R. Baker Nyree Griffin Wahyu Wulaningsih Mark Kelly Andrew R. Davies James A. Gossage 《British journal of cancer》2021,124(10):1653
Background A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study examines survival and recurrence patterns in these patients.Methods Clinicopathological factors were analysed using multivariable Cox regression assessing time to death and recurrence. Computed tomography-estimated tumour volume change was examined in a subgroup of consecutive patients.Results Five hundred and fifty-five patients were included. Median survival was 55 months (Mandard 1–3) and 21 months (Mandard 4 and 5). In the Mandard 4 and 5 group (332 patients), comparison between complete nodal responders and persistent nodal disease showed improved survival (90 vs 18 months), recurrence rates (locoregional 14.75 vs 28.74%, systemic 24.59 vs 48.42%) and circumferential resection margin positivity (22.95 vs 68.11%). Complete nodal response independently predicted improved survival (hazard ratio 0.34 (0.16–0.74). Post-chemotherapy tumour volume reduction was greater in patients with a complete nodal response (−16.3 vs −7.7 cm3, p = 0.033) with no significant difference between Mandard groups.Conclusion Patients with a complete nodal response to chemotherapy have significantly improved outcomes despite a poor Mandard score. High Mandard score does not correspond with a non-response to chemotherapy in all cases and patients with nodal downstaging may still benefit from adjuvant chemotherapy.Subject terms: Oesophageal cancer, Surgical oncology 相似文献
6.
In 1963, Goffman argued that forming a group based on shared stigma may provide benefits. However, there is no empirical research on whether perception that a separate, unique, coherent group exists (i.e., group entitativity) influences coping, such as educating others or secrecy, for the stigmatized individual or his or her spouse. Further, little is known about how spouses influence each other in terms of promoting the education of others about a stigmatizing condition, especially when it comes to the role of believing that stigma-based groups, to which they may both belong, exist. This study provides a step toward bridging this gap in the research by applying the label management model in efforts to understand coping for couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). This study included 50 married couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). We found that group entitativity related to those with AATD counterbalanced the influence of genetic stigma on spouses’ intentions to keep the diagnosis secret or to educate others about it. Intrapersonal and interpersonal influences appeared among spouses. Attention is needed on the power of creating groups for stigmatized persons and their relatives. Indeed, people live within a dynamic world of group entities, and multiple social identities including spousal and familial. While attention has been paid to the diffusion of stigmas to loved ones, less has been paid to the uplift of group entities for them. 相似文献
7.
8.
Michael E Egger Joanna M Ohlendorf Charles R Scoggins Kelly M McMasters Robert C G Martin II 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2015,17(9):839-845
BackgroundThe aim of this paper is to assess the current state of quality and outcomes measures being reported for hepatic resections in the recent literature.MethodsMedline and PubMed databases were searched for English language articles published between 1 January 2002 and 30 April 2013. Two examiners reviewed each article and relevant citations for appropriateness of inclusion, which excluded papers of liver donor hepatic resections, repeat hepatectomies or meta-analyses. Data were extracted and summarized by two examiners for analysis.ResultsFifty-five studies were identified with suitable reporting to assess peri-operative mortality in hepatic resections. In only 35% (19/55) of the studies was the follow-up time explicitly stated, and in 47% (26/55) of studies peri-operative mortality was limited to in-hospital or 30 days. The time period in which complications were captured was not explicitly stated in 19 out of 28 studies. The remaining studies only captured complications within 30 days of the index operation (8/28). There was a paucity of quality literature addressing truly patient-centred outcomes.ConclusionQuality outcomes after a hepatic resection are inconsistently reported in the literature. Quality outcome studies for a hepatectomy should report mortality and morbidity at a minimum of 90 days after surgery. 相似文献
9.
R. Foley P. Kelly S. Gatault F. Powell 《Journal of the European Academy of Dermatology and Venereology》2021,35(1):62-72
Demodex mites are microscopic arachnids found in the normal skin of many mammals. In humans, it is well established that Demodex mite density is higher in patients with the skin condition rosacea, and treatment with acaricidal agents is effective in resolving symptoms. However, pathophysiology of rosacea is complex and multifactorial. In dogs, demodicosis is a significant veterinary issue, particularly the generalized form of the disease which can be fatal if untreated. In each species, clinical and molecular studies have shown that the host’s immunological interactions with Demodex mites are an important, but not fully understood, aspect of how Demodex can live in the skin either as a harmless commensal organism or as a pathogenic agent. This review outlines the role of Demodex mites in humans and dogs, considering morphology, prevalence, symptoms, diagnosis, histology treatment and pathogenesis. 相似文献
10.